| Year |
Citation |
Score |
| 2022 |
Krolick KN, Shi H. Estrogenic Action in Stress-Induced Neuroendocrine Regulation of Energy Homeostasis. Cells. 11. PMID 35269500 DOI: 10.3390/cells11050879 |
0.376 |
|
| 2020 |
Xu M, Wang C, Krolick KN, Shi H, Zhu J. Difference in post-stress recovery of the gut microbiome and its altered metabolism after chronic adolescent stress in rats. Scientific Reports. 10: 3950. PMID 32127581 DOI: 10.1038/s41598-020-60862-1 |
0.412 |
|
| 2019 |
Zhu Q, Liu X, Glazier BJ, Krolick KN, Yang S, He J, Lo CC, Shi H. Differential Sympathetic Activation of Adipose Tissues by Brain-Derived Neurotrophic Factor. Biomolecules. 9. PMID 31492038 DOI: 10.3390/biom9090452 |
0.425 |
|
| 2018 |
Krolick KN, Zhu Q, Shi H. Effects of Estrogens on Central Nervous System Neurotransmission: Implications for Sex Differences in Mental Disorders. Progress in Molecular Biology and Translational Science. 160: 105-171. PMID 30470289 DOI: 10.1016/Bs.Pmbts.2018.07.008 |
0.388 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1992 |
Thompson PA, Barohn RA, Krolick KA. Repetitive nerve stimulation vs. twitch tension in rats with EAMG. Muscle & Nerve. 15: 94-100. PMID 1732768 DOI: 10.1002/mus.880150116 |
0.181 |
|
| 1992 |
Yeh TM, Tami JA, Krolick KA. Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravis. Drug and Chemical Toxicology. 15: 53-65. PMID 1555523 DOI: 10.3109/01480549209035172 |
0.172 |
|
| 1996 |
Krolick KA, Yeh TM, Edlund SA. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Cellular Immunology. 172: 10-20. PMID 8806801 DOI: 10.1006/cimm.1996.0209 |
0.169 |
|
| 2003 |
Garcia YR, Pothitakis JC, Krolick KA. Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis. Clinical Immunology (Orlando, Fla.). 106: 116-26. PMID 12672402 |
0.167 |
|
| 1989 |
Yeh TM, Krolick KA. Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen. Journal of Neuroimmunology. 24: 133-42. PMID 2478576 |
0.166 |
|
| 1987 |
Olsberg CA, Maxwell LC, Mikiten TM, Krolick KA. Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor. Journal of Neuroimmunology. 14: 253-66. PMID 3494040 |
0.162 |
|
| 1993 |
Zoda TE, Krolick KA. Antigen presentation and T cell specificity repertoire in determining responsiveness to an epitope important in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology. 43: 131-8. PMID 7681444 |
0.16 |
|
| 1995 |
Thompson PA, Edlund SA, Krolick KA. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis. Clinical Immunology and Immunopathology. 75: 57-67. PMID 7882593 |
0.154 |
|
| 2004 |
Garcia YR, Krolick KA. Short-circuiting autoimmune disease by target-tissue-derived nitric oxide Clinical Immunology. 113: 74-80. PMID 15380532 DOI: 10.1016/j.clim.2004.05.002 |
0.153 |
|
| 2000 |
Reyes-Reyna SM, Krolick KA. Chemokine production by rat myocytes exposed to interferon-gamma. Clinical Immunology (Orlando, Fla.). 94: 105-13. PMID 10637095 DOI: 10.1006/clim.1999.4828 |
0.152 |
|
| 1991 |
Zoda T, Yeh TM, Krolick KA. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats. Journal of Immunology (Baltimore, Md. : 1950). 146: 663-70. PMID 1987281 |
0.151 |
|
| 2010 |
Stacy S, Williams EL, Standifer NE, Pasquali A, Krolick KA, Infante AJ, Kraig E. Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 184: 6067-75. PMID 20435934 DOI: 10.4049/Jimmunol.0901618 |
0.149 |
|
| 1992 |
Thompson PA, Krolick KA. Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: Subsetting of serum antibodies by preparative isoelectric focusing Clinical Immunology and Immunopathology. 62: 199-209. PMID 1730158 DOI: 10.1016/0090-1229(92)90073-W |
0.147 |
|
| 1987 |
Yeh TM, Krolick KA. Influence of T cell specificity on the heterogeneity and disease-causing capability of antibody against the acetylcholine receptor. Journal of Neuroimmunology. 17: 17-34. PMID 2960692 |
0.147 |
|
| 2002 |
Reyes-Reyna S, Stegall T, Krolick KA. Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattractant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis. Journal of Immunology (Baltimore, Md. : 1950). 169: 1579-86. PMID 12133987 |
0.143 |
|
| 1995 |
Zoda TE, Brandon K, Krolick KA. Neonatal tolerance to an immunodominant T cell reactivity does not confer resistance to EAMG induction in Lewis rats. Journal of Neuroimmunology. 57: 35-44. PMID 7535790 |
0.139 |
|
| 2000 |
Stegall T, Krolick KA. A monoclonal lewis rat myocyte line that responds to interferon-gamma: responsiveness with the potential to influence subsequent interactions with the immune system. Clinical Immunology (Orlando, Fla.). 94: 125-32. PMID 10637097 DOI: 10.1006/clim.1999.4821 |
0.136 |
|
| 2002 |
Stacy S, Gelb BE, Koop BA, Windle JJ, Wall KA, Krolick KA, Infante AJ, Kraig E. Split tolerance in a novel transgenic model of autoimmune myasthenia gravis. Journal of Immunology (Baltimore, Md. : 1950). 169: 6570-9. PMID 12444169 DOI: 10.4049/Jimmunol.169.11.6570 |
0.132 |
|
| 2001 |
Garcia YR, May JJ, Green AM, Krolick KA. Acetylcholine receptor-reactive antibody induces nitric oxide production by a rat skeletal muscle cell line: influence of cytokine environment. Journal of Neuroimmunology. 120: 103-11. PMID 11694325 |
0.129 |
|
| 1990 |
Yeh TM, Krolick KA. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. Journal of Immunology (Baltimore, Md. : 1950). 144: 1654-60. PMID 2155265 |
0.126 |
|
| 2002 |
Stacy S, Krolick KA, Infante AJ, Kraig E. Immunological memory and late onset autoimmunity. Mechanisms of Ageing and Development. 123: 975-85. PMID 12044946 DOI: 10.1016/S0047-6374(02)00035-0 |
0.126 |
|
| 1989 |
Krolick KA. Selective elimination of autoreactive lymphocytes with immunotoxins. Clinical Immunology and Immunopathology. 50: 273-82. PMID 2645071 |
0.124 |
|
| 2006 |
Krolick KA. Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis. Clinical Immunology (Orlando, Fla.). 121: 286-93. PMID 16938490 DOI: 10.1016/j.clim.2006.07.005 |
0.122 |
|
| 1981 |
Muirhead MJ, Isakson PC, Krolick KA, Uhr JW, Vitetta ES. BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution. The American Journal of Pathology. 105: 295-305. PMID 7032308 |
0.122 |
|
| 1988 |
Brown RM, Krolick KA. Clonotypic analysis of the antibody response to the acetylcholine receptor in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology. 19: 205-22. PMID 3261738 |
0.116 |
|
| 2000 |
Rey E, Zeidel M, Rhine C, Tami J, Krolick K, Fischbach M, Sanz I. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries. Clinical Immunology (Orlando, Fla.). 96: 269-79. PMID 10964546 DOI: 10.1006/Clim.2000.4898 |
0.115 |
|
| 1985 |
Olsberg CA, Mikiten TM, Krolick KA. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin. Journal of Immunology (Baltimore, Md. : 1950). 135: 3062-7. PMID 3876374 |
0.115 |
|
| 1988 |
Brown RM, Krolick KA. Selective idiotype suppression of an adoptive secondary anti-acetylcholine receptor antibody response by immunotoxin treatment before transfer Journal of Immunology. 140: 893-898. PMID 3257507 |
0.113 |
|
| 1986 |
Krolick KA, Urso OE. Influence of T cell specificity on the antibody response to the acetylcholine receptor. Journal of Neuroimmunology. 13: 75-87. PMID 2428835 |
0.108 |
|
| 1981 |
Krolick KA, Sercarz EE. Changing behavior of surface immunoglobulin on mouse B lymphocytes during immune development. I. LPS-induced changes in the lateral mobility of B lymphocyte surface immunoglobulins on two populations which express different surface immunoglobulin phenotypes. Cellular Immunology. 65: 166-74. PMID 6976210 DOI: 10.1016/0008-8749(81)90061-7 |
0.108 |
|
| 2003 |
Stacy S, Infante AJ, Wall KA, Krolick K, Kraig E. Recall immune memory: a new tool for generating late onset autoimmune myasthenia gravis. Mechanisms of Ageing and Development. 124: 931-40. PMID 14499498 DOI: 10.1016/S0047-6374(03)00165-9 |
0.105 |
|
| 1994 |
Krolick KA, Zoda TE, Thompson PA. Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis. Advances in Neuroimmunology. 4: 475-93. PMID 7719619 |
0.103 |
|
| 2001 |
Stegall T, Krolick KA. Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis. Journal of Neuroimmunology. 119: 377-86. PMID 11585642 |
0.1 |
|
| 1996 |
Infante AJ, Infante PD, Jackson CE, Barohn RJ, Tami J, Iturriaga E, Talib S, Kraig E, Clarkin KZ, Krolick KA. Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis. Journal of Neuroscience Research. 45: 492-9. PMID 8872911 DOI: 10.1002/(Sici)1097-4547(19960815)45:4<492::Aid-Jnr20>3.0.Co;2-1 |
0.097 |
|
| 1993 |
Mohan S, Krolick KA. Inhibition of myosin ATPase activity by human myasthenia gravis antibodies reactive with the acetylcholine receptor. Febs Letters. 318: 50-2. PMID 8436225 |
0.096 |
|
| 1981 |
Krolick KA, Sercarz EE. Changing behavior of surface immunoglobulin on mouse B lymphocytes during immune development. II. Surface immunoglobulin modulation clearly distinguishes two stages of B-cell maturation in the neonate. Cellular Immunology. 65: 175-9. PMID 6976211 DOI: 10.1016/0008-8749(81)90062-9 |
0.094 |
|
| 1987 |
Tami JA, Urso OE, Krolick KA. T cell hybridomas reactive with the acetylcholine receptor and its subunits. Journal of Immunology (Baltimore, Md. : 1950). 138: 732-8. PMID 2949007 |
0.093 |
|
| 1988 |
Tami JA, Krolick KA. Analysis of helper T-cell specificity involved in the antibody response to the acetylcholine receptor. Annals of the New York Academy of Sciences. 540: 340-2. PMID 2462808 |
0.092 |
|
| 1994 |
Thompson PA, McAtee R, Infante AJ, Currier P, Beninati W, Krolick KA. V beta-specific immunotoxin selectively kills acetylcholine receptor-reactive T lymphocytes from mice with experimental autoimmune myasthenia gravis. International Immunology. 6: 1807-15. PMID 7696201 DOI: 10.1093/Intimm/6.12.1807 |
0.088 |
|
| 1991 |
Infante AJ, Thompson PA, Krolick KA, Wall KA. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. Journal of Immunology (Baltimore, Md. : 1950). 146: 2977-82. PMID 1707927 |
0.088 |
|
| 1994 |
Mohan S, Barohn RJ, Jackson CE, Krolick KA. Evaluation of myosin-reactive antibodies from a panel of myasthenia gravis patients. Clinical Immunology and Immunopathology. 70: 266-73. PMID 8313663 |
0.086 |
|
| 1981 |
Muirhead MJ, Vitetta ES, Isakson PC, Krolick KA, Dees JH, Uhr JW. Increased susceptibility to lethal effects of bacterial lipopolysaccharide in mice with B-cell leukemia Journal of the National Cancer Institute. 66: 745-753. PMID 6939920 |
0.085 |
|
| 1986 |
DeShambo RM, Krolick KA. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin. Journal of Immunology (Baltimore, Md. : 1950). 137: 3135-9. PMID 3490511 |
0.085 |
|
| 1980 |
Isakson PC, Krolick KA, Uhr JW, Vitetta ES. The effect of anti-immunoglobulin antibodies on the in vitro proliferation and differentiation of normal and neoplastic murine B cells Journal of Immunology. 125: 886-892. PMID 6771332 |
0.085 |
|
| 1992 |
Mohan S, Barohn RJ, Krolick KA. Unexpected cross-reactivity between myosin and a main immunogenic region (MIR) of the acetylcholine receptor by antisera obtained from myasthenia gravis patients. Clinical Immunology and Immunopathology. 64: 218-26. PMID 1643755 |
0.084 |
|
| 1979 |
Vitetta ES, Yuan D, Krolick K, Isakson P, Knapp M, Slavin S, Strober S. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. Journal of Immunology (Baltimore, Md. : 1950). 122: 1649-54. PMID 109513 |
0.081 |
|
| 2000 |
Stegall T, Krolick KA. Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis. Clinical Immunology (Orlando, Fla.). 94: 133-9. PMID 10637098 DOI: 10.1006/clim.1999.4822 |
0.081 |
|
| 1982 |
Krolick KA, Uhr JW, Slavin S, Vitetta ES. In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. The Journal of Experimental Medicine. 155: 1797-809. PMID 6804591 DOI: 10.1084/Jem.155.6.1797 |
0.078 |
|
| 1982 |
Krolick KA, Uhr JW, Vitetta ES. Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation. Nature. 295: 604-5. PMID 7035973 DOI: 10.1038/295604a0 |
0.076 |
|
| 1979 |
Krolick KA, Isakson PC, Uhr JW, Vitetta ES. BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor Immunological Reviews. 48: 81-106. PMID 94899 DOI: 10.1111/J.1600-065X.1979.Tb00299.X |
0.075 |
|
| 1991 |
Thompson PA, Krolick KA. Subsetting of acetylcholine receptor-reactive antibodies by preparative isoelectric focusing Preparative Biochemistry. 21: 229-235. PMID 1780274 DOI: 10.1080/10826069108018575 |
0.075 |
|
| 2023 |
Duff IT, Krolick KN, Mahmoud HM, Chidambaran V. Current Evidence for Biological Biomarkers and Mechanisms Underlying Acute to Chronic Pain Transition across the Pediatric Age Spectrum. Journal of Clinical Medicine. 12. PMID 37629218 DOI: 10.3390/jcm12165176 |
0.074 |
|
| 1980 |
Krolick KA, Villemez C, Isakson P, Uhr JW, Vitetta ES. Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin Proceedings of the National Academy of Sciences of the United States of America. 77: 5419-5423. PMID 6968912 DOI: 10.1073/pnas.77.9.5419 |
0.071 |
|
| 1989 |
Krolick KA. Inhibition of autoimmune reactivity against acetylcholine receptor with idiotype-specific immunotoxins. Methods in Enzymology. 178: 448-55. PMID 2601628 |
0.069 |
|
| 1979 |
Krolick KA, Isakson PC, Uhr JW, Vitetta ES. Murine B cell leukemia (BCL1): Organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody Journal of Immunology. 123: 1928-1935. PMID 385772 |
0.069 |
|
| 1993 |
Krolick KA, Thompson PA, Zoda TE, Yeh TM. Influence of immunological fine-specificity on the induction of experimental myasthenia gravis. Annals of the New York Academy of Sciences. 681: 179-97. PMID 7689305 |
0.068 |
|
| 1992 |
Infante AJ, Levcovitz H, Gordon V, Wall KA, Thompson PA, Krolick KA. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. Journal of Immunology (Baltimore, Md. : 1950). 148: 3385-90. PMID 1375242 |
0.067 |
|
| 1993 |
Infante AJ, Faler J, Chang S, Currier P, Thompson P, Krolick K, Zborowski K, Kraig E. T-cell receptor expression in murine myasthenia gravis. Annals of the New York Academy of Sciences. 681: 292-4. PMID 8357173 DOI: 10.1111/J.1749-6632.1993.Tb22898.X |
0.064 |
|
| 1977 |
Krolick KA, Wisnieski J, Sercarz EE. Differential lateral mobility of IgM and IgG receptors in mouse B lymphocyte membranes. Proceedings of the National Academy of Sciences of the United States of America. 74: 4595-9. PMID 337299 DOI: 10.1073/Pnas.74.10.4595 |
0.063 |
|
| 1980 |
Vitetta E, Krolick K. Allelic exclusion of IgD allotypes on murine B cells Journal of Immunology. 124: 2988-2990. PMID 6768803 |
0.063 |
|
| 1987 |
Krolick KA, Urso OE. Analysis of helper-T-cell function by acetylcholine receptor-reactive cell lines of defined AChR-subunit specificity. Cellular Immunology. 105: 75-85. PMID 2434253 |
0.059 |
|
| 1987 |
LeMaistra CF, Edwards DP, Krolick KA, McGuire WL. An immunotoxin cytotoxic for breast cancer cells in vitro Cancer Research. 47: 730-734. PMID 3492266 |
0.059 |
|
| 1980 |
Isakson PC, Uhr JW, Krolick KA, Finkelman F, Vitetta ES. Acquisition of cell surface IgD after in vitro culture of neoplastic B cells from the murine tumor BCL 1 Journal of Experimental Medicine. 151: 749-754. PMID 6987329 DOI: 10.1084/Jem.151.3.749 |
0.054 |
|
| 1983 |
Krolick KA, Uhr JW, Vitetta ES. Preparation and application of antibodies coupled to the A chain of ricin. Methods in Enzymology. 93: 333-8. PMID 6346013 |
0.047 |
|
| 1982 |
Vitetta ES, Krolick KA, Uhr JW. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins. Immunological Reviews. 62: 159-83. PMID 7042537 DOI: 10.1111/J.1600-065X.1982.Tb00393.X |
0.047 |
|
| 2009 |
Shandley S, Martinez S, Krolick K. IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4. Clinical Immunology (Orlando, Fla.). 132: 246-56. PMID 19395316 DOI: 10.1016/j.clim.2009.03.523 |
0.041 |
|
| 1983 |
Vitetta ES, Krolick KA, Miyama-Inaba M, Cushley W, Uhr JW. Immunotoxins: a new approach to cancer therapy. Science (New York, N.Y.). 219: 644-50. PMID 6218613 DOI: 10.1126/Science.6218613 |
0.017 |
|
| 2000 |
Infante AJ, Krolick KA, Wall KA. Reply to Balasa and Sarvetnick. Immunology Today. 21: 305-6. PMID 10825743 DOI: 10.1016/S0167-5699(00)01651-0 |
0.014 |
|
| Hide low-probability matches. |